Skip to main content
. Author manuscript; available in PMC: 2016 May 13.
Published in final edited form as: Microcirculation. 2016 May;23(4):301–310. doi: 10.1111/micc.12278

Figure 4.

Figure 4

Permeability to BSA under various treatments: S1P, BSA only, generic MMP inhibitor GM 6001, specific inhibitors to MMP-9 and -13, and negative control GM 6001 NC. *p < 0.001 compared to that under S1P treatment. n: number of vessels in each group.